Literature DB >> 28240145

Assessment of Mucosal Inflammation and Circulation in Response to Probiotics in Patients Operated with Ileal Pouch Anal Anastomosis for Ulcerative Colitis.

K O Laake1, P D Line1, L Aabakken1, T Løtveit1, A Bakka1, J Eide1, A Røsetti1, K Grzyb1, A Bjørneklett1, M H Vatn1.   

Abstract

BACKGROUND: Pouchitis is a common and troublesome condition, and a disturbed microbiological flora and mucosal blood flow in the pouch have been suggested as possible causes. Laser Doppler flowmetry (LDF) has been used successfully to measure gastric and colonic mucosal perfusion in humans. The aim of this study was to evaluate the effect of intervention with probiotics on ileal pouch inflammation and perfusion in the pouch, assessed by endoscopy, histology, fecal calprotectin and LDF.
METHODS: A fermented milk product (Cultura; 500 ml) containing live lactobacilli (La-5) and bifidobacteria (Bb-12) was given daily for 4 weeks to 10 patients operated with ileal-pouch-anal anastomosis (IPAA) for ulcerative colitis (UC). Mucosal perfusion was measured with LDF and the degree of inflammation was examined at predefined levels of the distal bowel by endoscopy and histology. Stool samples were cultured for lactobacilli and bifidobacteria and calprotectin were measured before and after intervention.
RESULTS: The LDF measurements were reproducible in the pelvic pouch at each of the predefined levels, but did not change after intervention. The mucosal perfusion was reduced in the distal compared to the proximal part of the pouch. Calprotectin levels did not change significantly after intervention. The median endoscopic score for inflammation was significantly reduced by 50% after intervention, whereas the histological score did not change significantly.
CONCLUSION: The results suggest that probiotics primarily act superficially, with change of gross appearance of the mucosa at endoscopy, but without significant effect on histological picture, mucosal perfusion or faecal calprotectin, during a relatively short period of 4 weeks.

Entities:  

Keywords:  Bifidobacteriae; endoscopic laser doppler flowmetry; ileal pouch; inflammation; lactobacilli; mucosal blood perfusion

Year:  2003        PMID: 28240145     DOI: 10.1080/00365520310000906

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  3 in total

Review 1.  Probiotics for the treatment of inflammatory bowel disease.

Authors:  Ganesh R Veerappan; John Betteridge; Patrick E Young
Journal:  Curr Gastroenterol Rep       Date:  2012-08

Review 2.  VSL#3 probiotic mixture: a review of its use in chronic inflammatory bowel diseases.

Authors:  Therese M Chapman; Greg L Plosker; David P Figgitt
Journal:  Drugs       Date:  2006       Impact factor: 9.546

Review 3.  Alteration of Gut Microbiota in Inflammatory Bowel Disease (IBD): Cause or Consequence? IBD Treatment Targeting the Gut Microbiome.

Authors:  Israr Khan; Naeem Ullah; Lajia Zha; Yanrui Bai; Ashiq Khan; Tang Zhao; Tuanjie Che; Chunjiang Zhang
Journal:  Pathogens       Date:  2019-08-13
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.